Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.54 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 8/20 | 0.50 |
| ▸ | HSP90AB1 | P08238 | 8/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22738260 | 0.88 | CYP1A2 (0.59) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL29360295 | 0.88 | NSD2 (0.54) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL214870 | 0.88 | NSD2 (0.54) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL29492615 | 0.86 | NSD2 (0.53) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL1840829 | 0.86 | NSD2 (0.53) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| Hydrochloric Acid SCHEMBL31134043 | 0.86 | PTPN22 (0.57) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL31410627 | 0.86 | NSD2 (0.53) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL9060865 | 0.86 | NSD2 (0.53) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL29027 | 0.84 | PTPN22 (0.65) | NSD2OPRM1OPRD1HKDC1PTPN22 | |
| SCHEMBL15400598 | 0.84 | PTPN22 (0.65) | NSD2OPRM1OPRD1HKDC1PTPN22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670585-B2 | Electrochemical coupling of a phenol to a naphthol | EVONIK DEGUSSA GMBH (DE) | 2017-06-06 | — | — | US | disclosed |
| US-9670585-B2 | Electrochemical coupling of a phenol to a naphthol | EVONIK DEGUSSA GMBH (DE) | 2017-06-06 | — | — | US | disclosed |
| US-20160017505-A1 | ELECTROCHEMICAL COUPLING OF A PHENOL TO A NAPHTHOL | EVONIK DEGUSSA GMBH (CH) | 2016-01-21 | — | — | US | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2376411-B1 | ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-12 | — | — | EP | disclosed |
| US-8580991-B2 | Aluminium complexes and use thereof as a catalyst in intramolecular ring closure reactions | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-8580991-B2 | Aluminium complexes and use thereof as a catalyst in intramolecular ring closure reactions | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20110082308-A1 | ALUMINUM COMPLEX AND USE THEREOF | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-04-07 | — | — | US | disclosed |
| US-20110082308-A1 | ALUMINUM COMPLEX AND USE THEREOF | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-04-07 | — | — | US | disclosed |
| EP-2279992-A1 | ALUMINUM COMPLEX AND USE THEREOF | Takasago International Corporation (JP) | 2011-02-02 | — | — | EP | disclosed |
| WO-2010071227-A1 | ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-06-24 | — | — | WO | disclosed |
| US-20050049306-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2005-03-03 | — | — | US | disclosed |
| US-6838583-B2 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and the methods of using the same | WARNER-LAMBERT COMPANY LLC (US) | 2005-01-04 | — | — | US | disclosed |
| EP-1409443-A2 | NON-HALOGENATED NAPHTHOL COMPOUNDS, ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | WARNER-LAMBERT COMPANY (US) | 2004-04-21 | — | — | EP | disclosed |
| US-20040010046-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC | 2004-01-15 | — | — | US | disclosed |
| US-20020110530-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2002-08-15 | — | — | US | disclosed |
| WO-2002050001-A2 | NON-HALOGENATED NAPHTHOL COMPOUNDS AND ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME | WARNER-LAMBERT COMPANY (US) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160017505-A1 | ELECTROCHEMICAL COUPLING OF A PHENOL TO A NAPHTHOL | NQO1, COMT, NQO2 | NSD2 3230/4885OPRM1 1940/4885OPRD1 1732/4885 |
| US-20050049306-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | NPM1, NOC2L, NAF1 | NSD2 1815/4885OPRM1 2578/4885OPRD1 3185/4885 |
| US-20040010046-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | NPM1, NOC2L, NAF1 | NSD2 1815/4885OPRM1 2578/4885OPRD1 3185/4885 |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | MSMO1, GGPS1, MAN1B1 | NSD2 2568/4885OPRM1 368/4885OPRD1 419/4885 |
| US-20020110530-A1 | Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same | NPM1, NOC2L, NAF1 | NSD2 1815/4885OPRM1 2578/4885OPRD1 3185/4885 |
| US-20110082308-A1 | ALUMINUM COMPLEX AND USE THEREOF | C9, ALOX12, ALOX5 | NSD2 4094/4885OPRM1 2449/4885OPRD1 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.